EDMUND CHADA BARACAT

(Fonte: Lattes)
Índice h a partir de 2011
35
Projetos de Pesquisa
Unidades Organizacionais
Departamento de Obstetrícia e Ginecologia, Faculdade de Medicina - Docente
Instituto Central, Hospital das Clínicas, Faculdade de Medicina
LIM/58 - Laboratório de Ginecologia Estrutural e Molecular, Hospital das Clínicas, Faculdade de Medicina - Líder

Resultados de Busca

Agora exibindo 1 - 10 de 46
  • conferenceObject
    The physical activity in postmenopause women and performance at Virtual Reality
    (2018) RAIMUNDO, Juliana Z.; RAIMUNDO, Rodrigo D.; ABREU, Luiz C. de; SOARES JUNIOR, Jose M.; SIMOES, Ricardo D.; NORBERTO, Alex R.; PEREIRA, Valdelias X.; SORPRESO, Isabel C.; BARACAT, Edmund C.
  • article 5 Citação(ões) na Scopus
    ER PvuII and XbaI polymorphisms in postmenopausal women with posterior tibial tendon dysfunction: a case control study
    (2018) PONTIN, P. A.; NOGARA, P. R. B.; FONSECA, F. C. P.; NETTO, C. Cesar; CARVALHO, K. C.; SOARES JUNIOR, J. M.; BARACAT, E. C.; FERNANDES, T. D.; MAFFULLI, N.; SANTOS, M. C. L.; GODOY-SANTOS, A. L.
    BackgroundPosterior tibial tendon (PTT) insufficiency is considered as the main cause of adult acquired flat foot and is three times more frequent in females. High estrogen levels exert a positive effect on the overall collagen synthesis in tendons. We have previously demonstrated the association between some genetic single-nucleotide polymorphism (SNP) and tendinopathy. In the present study, we investigated the association of PvuII c454-397T>C (NCBI ID: rs2234693) and XbaI c454-351A>G (NCBI ID: rs9340799) SNPs in estrogen receptor alfa (ER-) gene with PPT dysfunction.MethodsA total of 92 female subjects with PTT dysfunction, with histopathological examination of the tendon and magnetic resonance image (MRI) evidence of tendinopathy, were compared to 92 asymptomatic females who presented an intact PPT at MRI for PvuII and XbaI SNPs in the ER- gene. Genomic DNA was extracted from saliva and genotypes were obtained by polymerase chain reaction restriction fragment length polymorphism.ResultsThe analysis of PvuII SNPs showed no significant differences in the frequency of alleles and genotypes between control and PTT dysfunction groups. The XbaI SNPs in the ER- gene showed significant differences in the frequency of genotypes between control and test groups (p=0.01; OR 95% 1.14 (0.55-2.33).ConclusionsThe XbaI SNP in the ER gene may contribute to tendinopathy, and the A/A genotype could be a risk factor for PTT tendinopathy in this population. The PvuII SNP studied was not associated with PTT tendinopathy.
  • article 10 Citação(ões) na Scopus
    Isoflavones in gynecology
    (2018) CARBONEL, Adriana Aparecida Ferraz; SIMOES, Ricardo Santos; GIRAO, Joao Henrique Castello; SASSO, Gisela Rodrigues da Silva; BERTONCINI, Clelia Rejane Antonio; SORPRESO, Isabel Cristina Esposito; SOARES JUNIOR, Jose Maria; SIMOES, Manuel Jesus; BARACAT, Edmund Chada
  • conferenceObject
    A review of mobile voiding diary apps: Content and functionality features
    (2018) VACCARI, N.; SILVEIRA, L.; HADDAD, J.; BARACAT, E.; BERTOLINI, M. A.; FERREIRA, E.
  • conferenceObject
    Involvement of miRNA expression may contribute for FoxO3a oncogenic role in uterine leiomyosarcoma
    (2018) GARCIA, Natalia; RICCI, Anamaria Ritti; ALMEIDA, Bruna Cristine de; ALMEIDA, Thais Gomes; CUNHA, Isabela Werneck; BARACAT, Edmund Chada; CARVALHO, Katia Candido
  • article 118 Citação(ões) na Scopus
    Transvaginal Ultrasound for the Diagnosis of Adenomyosis: Systematic Review and Meta-Analysis
    (2018) ANDRES, Marina Paula; BORRELLI, Giuliano Moyses; RIBEIRO, Juliana; BARACAT, Edmund Chada; ABRAO, Mauricio Simoes; KHO, Rosanne M.
    Adenomyosis is characterized by the presence of ectopic foci of endometrial glandular tissue and/or stroma within the myometrium. The diagnosis of adenomyosis is traditionally made through histologic evaluation of the postsurgical specimen. More recently, imaging with transvaginal ultrasound (TVUS) has been used for the preoperative diagnosis of adenomyosis. As yet, there is no consensus regarding the best imaging feature or combination thereof for the nonsurgical diagnosis of adenomyosis. This study systematically evaluated the literature in the last 10 years to determine the accuracy of 2-dimensional (2D) TVUS, different imaging features, enhancing methods such as 3-dimensional (3D) TVUS, elastography and color Doppler in the nonsurgical diagnosis of adenomyosis. A total of 8 studies were included. Pooled sensitivity and specificity for 2D TVUS for the diagnosis of adenomyosis for all combined imaging characteristics was 83.8% and 63.9%, respectively. Pooled sensitivity for 355 total patients with use of imaging feature of heterogeneous myometrium with 2D TVUS was highest (86.0%), and pooled specificity for 283 total patients with use of globular uterus was highest (78.1%). After including the ""question mark"" sign with other TVUS features, higher sensitivity and specificity, of 92% and 88%, respectively, were noted. For 3D TVUS, pooled sensitivity and specificity for all combined imaging characteristics was 88.9% and 56.0%, respectively. Poor definition of junctional zone showed the highest pooled sensitivity (86%) and the highest pooled specificity (56.0%) for the diagnosis of adenomyosis with 3D TVUS. There was no improvement in overall accuracy in 3D TVUS compared with 2D TVUS. Preliminary results of TVUS with color Doppler showed a high sensitivity and specificity for the differentiation between adenomyosis and myomas (95.6% and 93.4%, respectively). Also, TVUS elastography in 1 study showed an improvement in specificity (82.9%) compared with 2D TVUS (63.9%), albeit with comparable sensitivity. Larger studies are needed to advance our understanding of the different types of adenomyosis and their clinical impact.
  • article 2 Citação(ões) na Scopus
    About the Anti-Mullerian Hormone (AMH) Uses in the Clinical Practice
    (2018) MACIEL, Gustavo Arantes Rosa; BARACAT, Edmund Chada; SA, Marcos Felipe Silva de
  • article 7 Citação(ões) na Scopus
    The effects of soybean isoflavones and 17-estradiol in uterus and mammary glands of diabetic rat models
    (2018) CARBONEL, Adriana Aparecida Ferraz; LIMA, Patricia Daniele Azevedo; LIM, Jung Jin; FUCHS, Luiz Fernando Portugal; PAIOTTI, Ana Paula Ribeiro; SASSO, Gisela Rodrigues da Silva; SIMOES, Ricardo Santos; SOARES JUNIOR, Jose Maria; BARACAT, Edmund Chada; SIMOES, Manuel de Jesus
    The objective of this study was to evaluate the action of soy isoflavones and 17 beta estradiol on the extracellular matrix in the uterus and mammary gland of diabetic rats. Sixty adult female rats underwent ovariectomy, then randomized into seven groups of ten animals each: Non-diabetic: GI Sham control animals ovariectomized; and GII control ovariectomized that received propylene glycol vehicle. Diabetic: GIII Sham control diabetic animals ovariectomized; GIV ovariectomized diabetic animals receiving propylene glycol vehicle; GV diabetic ovariectomized animals treated with soy isoflavones (150mg/kg by gavage); GVI ovariectomized diabetic rats treated with estrogen (17b-estradiol, 10mg/kg, subcutaneously); GVII diabetic ovariectomized animals treated with soy isoflavones (150 mg/kg by gavage), and with estrogen (17b-estradiol, 10 mg/kg combination therapy). Treatments occurred during 30 consecutive days. After animals euthanasia, a portion of the uterus was immersed in liquid nitrogen for molecular biology analysis, the other portion of uterus and mammary glands were removed and processed for paraffin embedding. Soy isoflavones (GV) and 17b estradiol improved the production of compounds of extracellular matrix, such as small leucine-rich proteoglycans (SLRPs). The combination of both therapies had an additive effect in SLRPs expression. Soy isoflavones contribute to the uterine integrity of SLRPs of diabetic rats.
  • article 56 Citação(ões) na Scopus
    B lymphocytes can be activated to act as antigen presenting cells to promote anti-tumor responses
    (2018) ROSSETTI, Renata Ariza Marques; LORENZI, Noely Paula Cristina; YOKOCHI, Kaori; ROSA, Maria Beatriz Sartor de Faria; BENEVIDES, Luciana; MARGARIDO, Paulo Francisco Ramos; BARACAT, Edmund Chada; CARVALHO, Jesus Paula; VILLA, Luisa Lina; LEPIQUE, Ana Paula
    Immune evasion by tumors includes several different mechanisms, including the inefficiency of antigen presenting cells (APCs) to trigger anti-tumor T cell responses. B lymphocytes may display a pro-tumoral role but can also be modulated to function as antigen presenting cells to T lymphocytes, capable of triggering anti-cancer immune responses. While dendritic cells, DCs, are the best APC population to activate naive T cells, DCs or their precursors, monocytes, are frequently modulated by tumors, displaying a tolerogenic phenotype in cancer patients. In patients with cervical cancer, we observed that monocyte derived DCs are tolerogenic, inhibiting allogeneic T cell activation compared to the same population obtained from patients with precursor lesions or cervicitis. In this work, we show that B lymphocytes from cervical cancer patients respond to treatment with sCD40L and IL-4 by increasing the CD80(+)CD86(+) population, therefore potentially increasing their ability to activate T cells. To test if B lymphocytes could actually trigger anti-tumor T cell responses, we designed an experimental model where we harvested T and B lymphocytes, or dendritic cells, from tumor bearing donors, and after APC stimulation, transplanted them, together with T cells into RAG1(-/-) recipients, previously injected with tumor cells. We were able to show that anti-CD40 activated B lymphocytes could trigger secondary T cell responses, dependent on MHC-II expression. Moreover, we showed that dendritic cells were resistant to the anti-CD40 treatment and unable to stimulate anti-tumor responses. In summary, our results suggest that B lymphocytes may be used as a tool for immunotherapy against cancer.